RETRACTED: Loss of Heterozygosity and DNA Methylation Affect Germline Fibroblast Growth Factor Receptor 4 Polymorphism to Direct Allelic Selection in Breast Cancer

The articles are therefore being retracted from The American Journal of Pathology by the American Society for Investigative Pathology (the owner and publisher) at the request of Dr. Ezzat and with the concurrence of the coauthors. Dr. Ezzat states, “On behalf of all of the other authors, we wish to state that we have collectively confirmed the validity and reproducibility of the findings reported in these articles. Nevertheless, we request that these papers be retracted.”